Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cervidil for Outpatient Pre-induction Cervical Ripening
NCT03806231Phase 3Terminated
- Sponsor
- Intermountain Health
- Start
- Aug 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dinoprostone in cervical ripening (CR), sponsored by Intermountain Health. Started Aug 2019; status: terminated.
02
Drugs
dinoprostone
03
Conditions
cervical ripening (CR)
Beyond the preview
Go deeper on NCT03806231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03806231.